Evoke Pharma Inc
Institutional Ownership & Holdings Analysis
About
evoke-pharma is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
| # | Institution | Value |
|---|---|---|
| 1 | Nantahala Capital Management, LLC(2025-03-31) | $407.4K |
| 2 | Bleichroeder LP(2025-03-31) | $189.1K |
| 3 | CITADEL ADVISORS LLC(2025-03-31) | $68.2K |
| 4 | UBS Group AG(2024-12-31) | $5.6K |
| 5 | Tower Research Capital LLC (TRC)(2025-03-31) | $586 |
| 6 | BlackRock, Inc.(2025-03-31) | $336 |
| 7 | SBI Securities Co., Ltd.(2025-03-31) | $206 |
| 8 | MORGAN STANLEY(2025-03-31) | $176 |
| 9 | NewEdge Advisors, LLC(2025-03-31) | $47 |
| 10 | BANK OF AMERICA CORP /DE/(2025-03-31) | $25 |
| 11 | CONCOURSE FINANCIAL GROUP SECURITIES, INC.(2025-03-31) | $0 |
As of 2025-03-31
Value:$407.4K
As of 2025-03-31
Value:$189.1K
As of 2025-03-31
Value:$68.2K
As of 2024-12-31
Value:$5.6K
As of 2025-03-31
Value:$586
As of 2025-03-31
Value:$336
As of 2025-03-31
Value:$206
As of 2025-03-31
Value:$176
As of 2025-03-31
Value:$47
As of 2025-03-31
Value:$25
As of 2025-03-31
Value:$0
Total Institutional Holders:11
Top 10 Holders Own:100.0%